WO1998054211A3 - Cyclodepsipeptides and pharmaceutical compositions containing them - Google Patents
Cyclodepsipeptides and pharmaceutical compositions containing them Download PDFInfo
- Publication number
- WO1998054211A3 WO1998054211A3 PCT/JP1998/002380 JP9802380W WO9854211A3 WO 1998054211 A3 WO1998054211 A3 WO 1998054211A3 JP 9802380 W JP9802380 W JP 9802380W WO 9854211 A3 WO9854211 A3 WO 9854211A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- lower alkyl
- alkyl group
- cyclodepsipeptides
- hydrogen atom
- Prior art date
Links
- 108010002156 Depsipeptides Proteins 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 230000002763 arrhythmic effect Effects 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 230000003177 cardiotonic effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 230000000304 vasodilatating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
This invention relates to the cyclodepsipeptide represented by formula (1), wherein R?1a, R1b and R1c¿ are a hydrogen atom or a methyl group, R?2 and R4¿ lower alkyl groups, and R3 a lower alkyl group or an aralkyl group. R?5 and R6¿ are a hydrogen, an alkyl group of 1 to 8 carbons or an aralkyl group (but not R5=R6=H), A and B are individually an ethylene group or a methylene group that is substituted by a lower alkyl group, X and Y represent -O- and -N(R1d)- in which R1d is a hydrogen atom or a methyl group, R?2 and R1d¿ of X, and/or R?4 and R1c¿ being capable of forming a nitrogen-containing ring together with the contiguous carbon and nitrogen atoms. This invention also provides a medicine containing this compound as an effective ingredient. These compounds have strong cardiotonic, antiarrhythnic and vasodilating effects without an arrhythmic side effect.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9/140111 | 1997-05-29 | ||
JP14011197 | 1997-05-29 | ||
JP9/276114 | 1997-10-08 | ||
JP27611497 | 1997-10-08 | ||
JP9308589A JPH11171897A (en) | 1997-05-29 | 1997-11-11 | Cyclic depsipeptide and medicine containing the same as active ingedient |
JP9/308589 | 1997-11-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1998054211A2 WO1998054211A2 (en) | 1998-12-03 |
WO1998054211A3 true WO1998054211A3 (en) | 1999-03-04 |
Family
ID=27318000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1998/002380 WO1998054211A2 (en) | 1997-05-29 | 1998-05-29 | Cyclodepsipeptides and pharmaceutical compositions containing them |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPH11171897A (en) |
WO (1) | WO1998054211A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004518716A (en) * | 2001-02-14 | 2004-06-24 | ドン ワ ファーマシューティカル インダストリアル カンパニー リミテッド | Pharmaceutical composition for prevention and treatment of osteoporosis |
JP6024880B2 (en) * | 2012-09-03 | 2016-11-16 | 国立大学法人東北大学 | Novel usage of cyclic depsipeptide |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03251597A (en) * | 1990-02-27 | 1991-11-11 | Mitsubishi Kasei Corp | Versaferrocide-based compound |
JPH04321698A (en) * | 1991-04-17 | 1992-11-11 | Asahi Chem Ind Co Ltd | Physiologically active substance m6124 and production thereof |
JPH07138290A (en) * | 1993-11-22 | 1995-05-30 | Meiji Milk Prod Co Ltd | Cardiotonic agent |
JPH07188286A (en) * | 1993-09-30 | 1995-07-25 | Meiji Milk Prod Co Ltd | Cyclic depsipeptide and cardiotonic agent containing the same |
JPH09315996A (en) * | 1996-05-27 | 1997-12-09 | Meiji Milk Prod Co Ltd | Cardiotonic agent and its production |
-
1997
- 1997-11-11 JP JP9308589A patent/JPH11171897A/en active Pending
-
1998
- 1998-05-29 WO PCT/JP1998/002380 patent/WO1998054211A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03251597A (en) * | 1990-02-27 | 1991-11-11 | Mitsubishi Kasei Corp | Versaferrocide-based compound |
JPH04321698A (en) * | 1991-04-17 | 1992-11-11 | Asahi Chem Ind Co Ltd | Physiologically active substance m6124 and production thereof |
JPH07188286A (en) * | 1993-09-30 | 1995-07-25 | Meiji Milk Prod Co Ltd | Cyclic depsipeptide and cardiotonic agent containing the same |
JPH07138290A (en) * | 1993-11-22 | 1995-05-30 | Meiji Milk Prod Co Ltd | Cardiotonic agent |
JPH09315996A (en) * | 1996-05-27 | 1997-12-09 | Meiji Milk Prod Co Ltd | Cardiotonic agent and its production |
Non-Patent Citations (20)
Title |
---|
BIOORG KHIM, vol. 1, no. 1, 1975, pages 25 - 32 * |
BIOORG KHIM, vol. 2, no. 12, 1976, pages 1597 - 1605 * |
CHEMICAL ABSTRACTS, vol. 83, no. 13, 29 September 1975, Columbus, Ohio, US; abstract no. 114870, IVANOV E.A.: "Conformational states of cyclopeptide systems XII" page 606; column 2; XP002085052 * |
CHEMICAL ABSTRACTS, vol. 83, no. 9, 1 September 1975, Columbus, Ohio, US; abstract no. 79585q, IVANOV E.A.: "Conformations of cyclopeptide systems IX" page 698; column 1; XP002085053 * |
CHEMICAL ABSTRACTS, vol. 86, no. 17, 25 April 1977, Columbus, Ohio, US; abstract no. 121764m, SHISHOVA E.A.: "Molecular and crxstal structure of a cyclic hexadepsipeptide" page 586; column 2; XP002085054 * |
DAS E.A.: "The identification of depsipeptides by chemical ionisation mass spectroscopy", J.ANTIBIOT., vol. XXXII, no. 6, June 1979 (1979-06-01), pages 569 - 574, XP002085049 * |
DATABASE WPI Section Ch Week 9151, Derwent World Patents Index; Class C02, AN 91-373598, XP002075565 * |
DATABASE WPI Section Ch Week 9252, Derwent World Patents Index; Class B03, AN 92-427199, XP002075567 * |
DATABASE WPI Section Ch Week 9534, Derwent World Patents Index; Class B04, AN 95-256991, XP002075564 * |
DATABASE WPI Section Ch Week 9538, Derwent World Patents Index; Class B04, AN 95-290422, XP002075563 * |
DATABASE WPI Section Ch Week 9808, Derwent World Patents Index; Class B03, AN 98-082574, XP002075566 * |
GILLIS E.A.: "Isolation and structure of sporidesmolide V from cultures of P.chartarum", CAN.J.CHEM., vol. 68, 1990, pages 19 - 21, XP002085050 * |
GIRALT E.A.: "peptides 90, proceedings 21st EPS", ESCOM, LEIDEN, XP002075562 * |
KHIM.PRIR. SOEDIN, vol. 11, no. 1, 1975, pages 63 - 69 * |
KRASNOFF E.A.: "New destruxins from the entomopathogenic fungus Aschersonia sp.", J.NAT.PROD., vol. 59, no. 5, May 1996 (1996-05-01), pages 485 - 489, XP002075558 * |
LOSSE E.A.: "Synthese von Enniatin-B-analogen mit D-valin anstelle von D-Alpha-hydroxyvaleriansäure", TETRAHEDRON, vol. 25, 1969, pages 2677 - 2685, XP002075560 * |
LOUTELIER E.A.: "Studies on the dynamics of the production of destruxins by M.anisopliae", J.CHROM. A, vol. 738, 1996, pages 181 - 189, XP002075557 * |
TSUNOO E.A.: "Roseocardin, a novel cardiotonic cyclodepsipeptide from T.roseum TT103", J.ANTIBIOT., vol. 50, no. 12, December 1997 (1997-12-01), pages 1007 - 1013, XP002075561 * |
YEH E.A.: "Study of structure-activity corelation in destruxins, a class of cyclodepsipeptides possessing suppressive effect on the generation of Hepatitis B virus surface antigen in human hepatoma cells", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 229, no. 1, 1996, ORLANDO, FL US, pages 65-72, XP002075559 * |
ZERVAS: "Peptides, proc.6th EPS, Athens, September 1963", 1966, PERGAMON PRESS, OXFORD, XP002085051 * |
Also Published As
Publication number | Publication date |
---|---|
JPH11171897A (en) | 1999-06-29 |
WO1998054211A2 (en) | 1998-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2167673A1 (en) | Condensed benzazepine derivative and pharmaceutical composition thereof | |
CA2086404A1 (en) | Triazolopyrimidine derivatives | |
HUP9802708A2 (en) | Bicyclic amine derivatives, their intermediates, preparation thereof, insecticide, acaricide and nematocide compositions containing these compounds as active ingredients and use thereof | |
WO2001042216A3 (en) | Caspase inhibitors and uses thereof | |
EP1361220A4 (en) | Cyclic compounds having thrombopoietin receptor agonism | |
AU4218093A (en) | New peptides derived from trifluoromethyl ketones, process for their preparation and the pharmaceutical compositions which contain them | |
AU672267B2 (en) | Triazolopyrimidine derivatives | |
IL133891A0 (en) | 2-valproenoic acid amide derivatives, their preparation and pharmaceutical compositions containing them | |
WO2001009103A3 (en) | Imidazole antiproliferative agents | |
IL101839A0 (en) | Peptide compounds,processes for the preparation thereof,and pharmaceutical compositions containing the same | |
AU4627097A (en) | Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same | |
ES8504653A1 (en) | Fungicidally active compositions containing ethene derivatives. | |
IE891199L (en) | 2-alkyl-3-benzoylbenzofurans and pharmaceutical compositions¹containing them | |
EP0721945A4 (en) | Benzolactam derivative | |
WO1998053790A3 (en) | Compounds that inhibit the binding of vascular endothelial growth factor to its receptors | |
WO1998054211A3 (en) | Cyclodepsipeptides and pharmaceutical compositions containing them | |
MY108849A (en) | Novel compound | |
HU9401951D0 (en) | Serotoninergic ergoline derivatives | |
TW259785B (en) | Chemical compounds | |
ES8701174A1 (en) | Thiadiazine compound, process for its preparation and pharmaceutical compositions containing it. | |
GB1421446A (en) | Disalkylamino esters of benzopyranopyridines and compositions containing the same | |
HK1024909A1 (en) | Benzo(5,6)cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors | |
GB9125970D0 (en) | New compounds | |
IT1147330B (en) | CYSTOSTATIC ACTION, OR PHARMACEUTICAL PREPARATION | |
AU7032594A (en) | Azoxycyanobenzene derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): CA US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |